{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:47:49Z","timestamp":1791103669024,"version":"4.1.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1097\/grf.0b013e3182836b6a","type":"journal-article","created":{"date-parts":[[2013,1,19]],"date-time":"2013-01-19T11:56:54Z","timestamp":1358596614000},"page":"44-50","source":"Crossref","is-referenced-by-count":32,"title":["2012 Cervical Cancer Screening Guidelines and the Future Role of HPV Testing"],"prefix":"10.1097","volume":"56","author":[{"given":"ANNA M.","family":"PRIEBE","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210126","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics.","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"R2-8-20210126","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012.","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"R3-8-20210126","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3322\/caac.21139","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"R4-8-20210126","doi-asserted-by":"crossref","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","article-title":"Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.","volume":"156","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"key":"R5-8-20210126","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","article-title":"Classification of papillomaviruses.","volume":"324","author":"de Villiers","year":"2004","journal-title":"Virology"},{"key":"R6-8-20210126","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.vaccine.2006.05.115","article-title":"HPV in the etiology of human cancer.","volume":"24","author":"Munoz","year":"2006","journal-title":"Vaccine"},{"key":"R7-8-20210126","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/jmv.22081","article-title":"Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.","volume":"83","author":"Coutlee","year":"2011","journal-title":"J Med Virol"},{"key":"R8-8-20210126","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer.","volume":"55","author":"Bosch","year":"2002","journal-title":"J Clin Pathol"},{"key":"R9-8-20210126","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"R10-8-20210126","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer.","volume":"348","author":"Munoz","year":"2003","journal-title":"N Engl J Med"},{"key":"R11-8-20210126","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.","volume":"121","author":"Smith","year":"2007","journal-title":"Int J Cancer"},{"key":"R12-8-20210126","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1086\/428850","article-title":"Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica.","volume":"191","author":"Herrero","year":"2005","journal-title":"J Infect Dis"},{"key":"R13-8-20210126","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women.","volume":"338","author":"Ho","year":"1998","journal-title":"N Engl J Med"},{"key":"R14-8-20210126","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1086\/315086","article-title":"Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer.","volume":"180","author":"Franco","year":"1999","journal-title":"J Infect Dis"},{"key":"R15-8-20210126","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/bmj.325.7364.572","article-title":"Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study.","volume":"325","author":"Kjaer","year":"2002","journal-title":"BMJ"},{"key":"R16-8-20210126","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.","volume":"357","author":"Mayrand","year":"2007","journal-title":"N Engl J Med"},{"key":"R17-8-20210126","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and Papanicolaou tests to screen for cervical cancer.","volume":"357","author":"Naucler","year":"2007","journal-title":"N Engl J Med"},{"key":"R18-8-20210126","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","article-title":"Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial.","volume":"370","author":"Bulkmans","year":"2007","journal-title":"Lancet"},{"key":"R19-8-20210126","doi-asserted-by":"crossref","first-page":"a1754","DOI":"10.1136\/bmj.a1754","article-title":"Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study.","volume":"337","author":"Dillner","year":"2008","journal-title":"BMJ"},{"key":"R20-8-20210126","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00003081-201303000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T01:55:55Z","timestamp":1618365355000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003081-201303000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0b013e3182836b6a","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}